These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 190782)

  • 41. The effect of cerulenin on the synthesis of the precursor gag polyprotein in defective murine leukemia and sarcoma virus producing cell lines.
    Ikuta K; Coward J; Luftig RB
    Virology; 1986 Oct; 154(1):207-13. PubMed ID: 3019002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A candidate rat-specific gene product of the Kirsten murine sarcoma virus.
    Anderson GR; Marotti KR; Whitaker-Dowling PA
    Virology; 1979 Nov; 99(1):31-48. PubMed ID: 227164
    [No Abstract]   [Full Text] [Related]  

  • 43. Sarcoma and transformation-defective viruses produced with infectious DNA(s) from Rous sarcoma virus (RSV)-transformed chicken cells.
    Hillova J; Dantchev D; Mariage R; Plichon MP; Hill M
    Virology; 1974 Nov; 62(1):197-208. PubMed ID: 4371384
    [No Abstract]   [Full Text] [Related]  

  • 44. Revertants of human cells transformed by murine sarcoma virus.
    Cho HY; Cutchins EC; Rhim JS; Huebner RJ
    Science; 1976 Nov; 194(4268):951-3. PubMed ID: 62397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of interferon on murine leukemia virus infection. III. Effect of interferon on MSV-induced transformation.
    Pitha PM; Staal SP
    Virology; 1978 Oct; 90(1):151-5. PubMed ID: 213891
    [No Abstract]   [Full Text] [Related]  

  • 46. Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses.
    Henderson IC; Lieber MM; Todaro GJ
    Virology; 1974 Jul; 60(1):282-7. PubMed ID: 4366800
    [No Abstract]   [Full Text] [Related]  

  • 47. Viral glycoprotein synthesis under conditions of glucosamine block in cells transformed by avian sarcoma viruses.
    Lewandowski LJ; Smith RE; Bolognesi DP; Halpern MS
    Virology; 1975 Aug; 66(2):347-55. PubMed ID: 168682
    [No Abstract]   [Full Text] [Related]  

  • 48. Revertants of mouse cells transformed by murine sarcoma virus. V. Loss of MSV-specific nucleotide sequences from cellular RNA.
    Nomura S
    Virology; 1978 Dec; 91(2):444-52. PubMed ID: 217157
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia.
    Scher CD
    J Exp Med; 1978 Apr; 147(4):1044-53. PubMed ID: 206644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncornavirus budding: kinetics of formation and utilization of viral membrane glycoprotein.
    Witte ON; Weissman IL
    Virology; 1976 Feb; 69(2):464-73. PubMed ID: 176781
    [No Abstract]   [Full Text] [Related]  

  • 51. Sarcoma-negative leukemia-positive transformed cell culture established from a murine sarcoma virus-induced rat bone tumor.
    Chan JC; East JL; Dmochowski L
    Cancer Res; 1975 Sep; 35(9):2475-81. PubMed ID: 167960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluordeoxyuridine and colcemid.
    Nomura S; Fischinger PJ; Mattern CF; Gerwin BI; Dunn KJ
    Virology; 1973 Nov; 56(1):152-63. PubMed ID: 4126841
    [No Abstract]   [Full Text] [Related]  

  • 53. Replication-defective S+L-Moloney MSV codes for an envelope glycoprotein with moloney MuLV- and MCF-MuLV-specific determinants.
    Reynolds FH; Rapp UR; Todaro GJ; Stephenson JR
    Virology; 1979 Mar; 93(2):582-8. PubMed ID: 88125
    [No Abstract]   [Full Text] [Related]  

  • 54. Control of gene expression in rat cells transformed by a cold-sensitive murine sarcoma virus (MSV) mutant.
    Somers KD; May JT; Kit S
    Intervirology; 1973; 1(3):176-84. PubMed ID: 4359760
    [No Abstract]   [Full Text] [Related]  

  • 55. Continued presence of similar transformation-associated antigens related to murine oncornavirus proteins in -ransformed cells, morphological revertants, and cells restricted in the expression of transformation.
    Rieber M; Bacalao J; Rieber M
    Cancer Res; 1977 Apr; 37(4):1170-4. PubMed ID: 191180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.
    Todaro GJ; De Larco JE; Cohen S
    Nature; 1976 Nov; 264(5581):26-31. PubMed ID: 187944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of and alterations to defective murine sarcoma virus particles lacking envelope proteins and core polyprotein cleavage.
    Demsey A; Collins F; Kawka D
    J Virol; 1980 Dec; 36(3):872-7. PubMed ID: 6257930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sarcoma-virus-related RNA sequences in normal rat cells.
    Tsuchida N; Gilden RV; Hatanaka M
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4503-7. PubMed ID: 4140505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Asp56/LDHk in the Kirsten and Harvey sarcoma virus systems.
    Anderson GR; Farkas BK
    Transplant Proc; 1984 Apr; 16(2):449-51. PubMed ID: 6326355
    [No Abstract]   [Full Text] [Related]  

  • 60. Envelope properties of murine sarcoma virus-zero (MSV-Z).
    Nomura S
    Virology; 1980 Feb; 101(1):300-3. PubMed ID: 6243828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.